These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Localization of L-glutamate and L-aspartate synaptic receptors in chick retinal neurons. López-Colomé AM; Somohano F Brain Res; 1984 Apr; 298(1):159-62. PubMed ID: 6144357 [TBL] [Abstract][Full Text] [Related]
6. [Mechanism of action of kainic acid on L-glutamate receptors of pyramidal neurons in the rat hippocampus]. Kiskin NI; Kryshtal' OA; Tsyndrenko AIa Dokl Akad Nauk SSSR; 1985; 285(5):1221-4. PubMed ID: 2417799 [No Abstract] [Full Text] [Related]
7. [Neurotoxicity of kainic acid and its uses]. Yao DF; Zhang YF Sheng Li Ke Xue Jin Zhan; 1986 Jan; 17(1):55-7. PubMed ID: 3016889 [No Abstract] [Full Text] [Related]
8. Radioreceptor binding studies with glutamate and aspartate. Roberts PJ; Sharif NA Adv Biochem Psychopharmacol; 1981; 27():295-305. PubMed ID: 6255761 [No Abstract] [Full Text] [Related]
9. Effects of excitatory amino acids, and of their agonists and antagonists on the release of neurotransmitters from the chick retina. Morán J; Pasantes-Morales H J Neurosci Res; 1983; 10(3):261-71. PubMed ID: 6139487 [TBL] [Abstract][Full Text] [Related]
11. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease. Coyle JT; Ferkany JW; Zaczek R Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425 [TBL] [Abstract][Full Text] [Related]
12. Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Coyle JT; Bird SJ; Evans RH; Gulley RL; Nadler JV; Nicklas WJ; Olney JW Neurosci Res Program Bull; 1981; 19(4):1-427. PubMed ID: 6116209 [No Abstract] [Full Text] [Related]
13. Receptors for excitatory amino acids: binding studies and stimulation of cyclic GMP levels. Roberts PJ Adv Biochem Psychopharmacol; 1981; 29():379-86. PubMed ID: 6266222 [TBL] [Abstract][Full Text] [Related]
14. Biochemical development of the human brain. III. Benzodiazepine receptors, free gamma-aminobutyrate (GABA) and other amino acids. Brooksbank BW; Atkinson DJ; Balázs R J Neurosci Res; 1982; 8(4):581-94. PubMed ID: 6131141 [TBL] [Abstract][Full Text] [Related]
16. A competitive inhibitor of kainic acid binding from the goldfish nervous tissue. Migani P Brain Res; 1990 Jun; 518(1-2):179-85. PubMed ID: 2167747 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of kainic acid on benzodiazepine receptors, GABA receptors, and GABA-modulin in the cerebellar cortex. Biggio G; Corda MG; De Montis G; Gessa GL Adv Biochem Psychopharmacol; 1980; 21():265-70. PubMed ID: 6246741 [No Abstract] [Full Text] [Related]
18. Neurochemical and neuropharmacological indications for the involvement of GABA and glycine receptors in neuropsychiatric disorders. Lloyd KG; DeMontis G; Broekkamp CL; Thuret F; Worms P Adv Biochem Psychopharmacol; 1983; 37():137-48. PubMed ID: 6138947 [TBL] [Abstract][Full Text] [Related]
19. Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Klockgether T; Turski L Ann Neurol; 1993 Oct; 34(4):585-93. PubMed ID: 7692810 [TBL] [Abstract][Full Text] [Related]
20. Trophic actions of GABA on the development of physiologically active GABA receptors. Meier E; Drejer J; Schousboe A Adv Biochem Psychopharmacol; 1983; 37():47-58. PubMed ID: 6314772 [No Abstract] [Full Text] [Related] [Next] [New Search]